Atlas Trials

Investigating Idetrexed and Olaparib in Patients With Ovarian Cancer

Clinical trial NCT06976892 · RECRUITING

Trial details

NCT number
NCT06976892
Sponsor
Institute of Cancer Research, United Kingdom
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
High Grade Serous Ovarian Cancer
Start date
2025-08-01
Primary completion
2029-12-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.